Log In
BCIQ
Print this Print this
 

Lipocurc, liposomal curcumin

  Manage Alerts
Collapse Summary General Information
Company SignPath Pharma Inc.
DescriptionSynthesized curcumin
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I/II
Standard Indication Cancer (unspecified)
Indication DetailsTreat locally advanced or metastatic cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today